FDA Import Refusal 799-1504412-6/11/1 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA refused shipment 799-1504412-6/11/1 from IPR Pharmaceuticals, Inc. (United States) on March 23, 2021. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 23, 2021
Country
United States
Product Category
Drugs and Biologics
Product Code
61JCA16 ROSUVASTATIN CALCIUM
Charges
75